SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: scorman111/8/2024 6:00:29 PM
3 Recommendations

Recommended By
erickerickson
erippetoe
Olecranon

   of 63307
 
AVXL strange action today.
Up 21% on 3.5x daily volume on no IGN.
I cannot believe that the CTAD pitch based on a trial completed 2 years ago moved anything. Reading the SA article, the company point about safety profile is debunked by 31% dropouts rate due too treatment related complications. I had always argued that their "titration" dosage adjustment indicated a serious artifact for treatment.
IMHO, someone knows something we the public does not.
I am still holdingon my original 18k at a cost basis of $9, so I am waiting for a selling opportunity if the EMA submission is in fact placed before YE.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News